Astal Laboratories Ltd.

40.88 ▼0%

29 April 2024, 04:01:00 PM

Company Profile

Sector Trading Sector Icon Trading Compare with Sector peers
Industry Trading Industry Icon Trading Compare with Industry peers
Website http://www.miel.co.in
Market Cap 40.19 Cr.
Enterprise Value(EV) 40.19 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.63 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 64.50 Trailing Twelve Months Ending 2023-12
Industry PE 66.12 Trailing Twelve Months Ending 2023-12
Book Value / Share 23.46 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.74 Calculated using Price: 40.88
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.98 Cr. 9,830,070 Shares
FaceValue 10
About Astal Laboratories Ltd.
Macro International has been the leading manufacturer and supplier of neoprene sheets, neoprene rolls, and neoprene products in North America. With over three decades of company history and continued excellence.

Astal Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Astal Laboratories Ltd. Performance

1 Day
1 Week
1 Month
3 Month
+10.22%
6 Month
+21.49%
1 Year
+31.57%
2 Year
+66.18%
5 Year
+344.83%
10 Year
+85.82%

Astal Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 3.57 0.16 0.1 -0.13 -1.57 -0.54 0.12 -0.33 0.32
Return on Capital Employed (%) 0.97 0.36 0.2 -0.09 -1.44 -0.54 0.16 -0.33 0.62
Return on Assets (%) 3.35 0.15 0.1 -0.12 -1.53 -0.53 0.11 -0.32 0.22

Astal Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 5 5 5 5 5 5 5 5 5 5
Non Curr. Liab. 0 0 0 5
Curr. Liab. 0 0 0 0 0 0 0 0 5 2
Minority Int.
Equity & Liab. 5 5 5 5 5 5 5 5 10 12
Non Curr. Assets 0 0 0 0 0 0 0 5 4 4
Curr. Assets 5 5 5 5 5 5 5 0 6 8
Misc. Exp. not W/O
Total Assets 5 5 5 5 5 5 5 5 10 12

Astal Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 3 15
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 0 0 0 0 4 15
Total Expenditure 0 0 0 0 0 0 0 0 -4 -14
PBIDT 0 0 0 0 0 0 0 0 1
Interest
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 1
Adjusted EPS 0 0 0 0 0 0 0 0 0 1

Astal Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 0 0 0 0 0 0 0 0 -1
Cash Fr. Inv. 1 0 0 0 0 0 0 0 0 0
Cash Fr. Finan. 1
Net Change 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Astal Laboratories Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 66.81 66.81 68.18 68.18 68.18 61.13 55.72 39.79 19.93
Public 33.19 33.19 31.82 31.82 31.82 38.87 44.28 60.21 80.07
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Astal Laboratories Ltd. Announcements

Tue, 23 Apr 2024
Announcement under Regulation 30 (LODR)-Change of Company Name
Submission of intimation of Change of Name of the Company and fresh incorporation certificate.
Tue, 16 Apr 2024
Compliance Certificate Under Reg. 7 (3) For The Year Ended 31St March 2024.
Submission of Compliance Certificate under Reg. 7 (3) for the year ended 31st March 2024
Tue, 16 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyMacro International Ltd
2CIN NO.L74120UP1993PLC015605
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Mahendra Kumar
Designation: Company Secretary and Compliance officer
EmailId: csmahendra07@gmail.com
Name of the Chief Financial Officer: BALAYOGISWARA RAO PEDDINTI
Designation: Chief Financial officer
EmailId: sendmail2pbalu@gmail.com

Date: 16/04/2024

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Astal Laboratories Ltd. Technical Scans

Mon, 29 Apr 2024
Opening at High Opening at High
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Astal Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 341,236.54 2,990.45 -1.5%
Redington Ltd. 17,058.32 218.20 -0.1%
Honasa Consumer Ltd. 13,613.39 422.00 -0.6%
MMTC Ltd. 11,091.00 73.94 -1.3%
Lloyds Enterprises Ltd. 4,808.64 37.80 -2.8%
Entero Healthcare Solutions Ltd. 4,775.62 1,098.00 -2.7%
Veritas (India) Ltd. 3,930.61 1,466.10 -2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2024-03 105.29 2,990.45 -1.5%
Redington Ltd. Consolidated 2023-12 14.18 218.20 -0.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 422.00 -0.6%
MMTC Ltd. Consolidated 2023-12 83.86 73.94 -1.3%
Lloyds Enterprises Ltd. Consolidated 2024-03 40.90 37.80 -2.8%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.00 1,098.00 -2.7%
Veritas (India) Ltd. Consolidated 2023-12 20.51 1,466.10 -2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2024-03 8.73 2,990.45 -1.5%
Redington Ltd. Consolidated 2023-12 2.35 218.20 -0.1%
Honasa Consumer Ltd. Consolidated 2023-03 20.67 422.00 -0.6%
MMTC Ltd. Consolidated 2023-12 7.55 73.94 -1.3%
Lloyds Enterprises Ltd. Consolidated 2024-03 3.18 37.80 -2.8%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 3.05 1,098.00 -2.7%
Veritas (India) Ltd. Consolidated 2023-12 1.58 1,466.10 -2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 1.16 2,990.45 -1.5%
Redington Ltd. Consolidated 2023-03 0.45 218.20 -0.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.01 422.00 -0.6%
MMTC Ltd. Consolidated 2023-03 0.14 73.94 -1.3%
Lloyds Enterprises Ltd. Consolidated 2023-03 0.06 37.80 -2.8%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.63 1,098.00 -2.7%
Veritas (India) Ltd. Consolidated 2023-03 0.10 1,466.10 -2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 2,990.45 -1.5%
Redington Ltd. Consolidated 2023-03 22.66 218.20 -0.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 422.00 -0.6%
MMTC Ltd. Consolidated 2023-03 247.70 73.94 -1.3%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 37.80 -2.8%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.00 1,098.00 -2.7%
Veritas (India) Ltd. Consolidated 2023-03 4.30 1,466.10 -2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 2,990.45 -1.5%
Redington Ltd. Consolidated 2023-03 22.66 218.20 -0.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 422.00 -0.6%
MMTC Ltd. Consolidated 2023-03 247.70 73.94 -1.3%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 37.80 -2.8%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.00 1,098.00 -2.7%
Veritas (India) Ltd. Consolidated 2023-03 4.30 1,466.10 -2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 136,977.76 2,990.45 -1.5%
Redington Ltd. Consolidated 2023-03 79,376.78 218.20 -0.1%
Honasa Consumer Ltd. Consolidated 2023-03 1,492.75 422.00 -0.6%
MMTC Ltd. Consolidated 2023-03 3,528.18 73.94 -1.3%
Lloyds Enterprises Ltd. Consolidated 2023-03 380.30 37.80 -2.8%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 3,300.21 1,098.00 -2.7%
Veritas (India) Ltd. Consolidated 2023-03 2,163.22 1,466.10 -2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 2,208.94 2,990.45 -1.5%
Redington Ltd. Consolidated 2023-03 1,439.39 218.20 -0.1%
Honasa Consumer Ltd. Consolidated 2023-03 -150.97 422.00 -0.6%
MMTC Ltd. Consolidated 2023-03 1,562.27 73.94 -1.3%
Lloyds Enterprises Ltd. Consolidated 2023-03 45.03 37.80 -2.8%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 -11.10 1,098.00 -2.7%
Veritas (India) Ltd. Consolidated 2023-03 94.81 1,466.10 -2.0%

Astal Laboratories Ltd. FAQ's

What is Astal Laboratories share price?

Can I buy Astal Laboratories shares now?

What is the Market Cap of Astal Laboratories?

What are the key metrics to analyse Astal Laboratories?

What is the 52 Week High and Low of Astal Laboratories?